CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Interval From Initiation of Prasugrel to Coronary Angiography in Patients With Non–ST-Segment Elevation Myocardial Infarction Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN I study Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes Reappraisal of Reported Genes for Sudden Arrhythmic Death: An Evidence-Based Evaluation of Gene Validity for Brugada Syndrome Advances in Clinical Cardiology 2020: A Summary of Key Clinical Trials 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed

Guideline2016 Mar 15;67(10):1235-1250.

JOURNAL:J Am Coll Cardiol. Article Link

2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction

Levine GN, Bates ER, Blankenship JC et al. Keywords: ACC/AHA Clinical Practice Guideline; culprit vessel; focused update; multivessel; myocardial infarction; primary PCI; thrombectomy